Skip to main content
Equibles

MORGAN STANLEY

Position in ATOS — Atossa Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to ATOS Full portfolio

Position in ATOS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$23,825
-$61,397 QoQ
Shares Held
12,345
-23.8% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 31 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in ATOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ATOS ranks #391 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ATOS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,825 12,345
2026-03-31 $85,222 16,202
2025-12-31 $36,284 61,500
2025-09-30 $97,741 112,348
2025-06-30 $133,555 160,912
2025-03-31 $190,404 284,187
2024-12-31 $425,060 452,196
2024-09-30 $695,428 457,520
2024-06-30 $542,819 456,153
2024-03-31 $1,377,742 765,413
2023-12-31 $101,028 114,806
2023-09-30 $110,818 149,757
2023-06-30 $246,821 195,891
2023-03-31 $122,943 170,755
2022-12-31 $102,655 193,690
2022-09-30 $152,556 183,805
2022-06-30 $290,363 266,390
2022-03-31 $184,493 147,595
2021-12-31 $246,337 153,962
2021-09-30 $776,289 238,126
2021-06-30 $1,971,667 311,973
2021-03-31 $417,215 197,733
2020-12-31 $25 27
2020-09-30 $318,367 131,557
2020-06-30 $418 110
2020-03-31 $146 110